Taxanes are the most active drugs in the treatment of metastatic breast and ovarian cancer. Weekly therapy with paclitaxel produces notable activity, with remarkably low toxicity.
Ulrich Canzler, MD
Advertisement
Articles by Ulrich Canzler, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Priority Review to Giredestrant in ER+/HER2– Early Breast Cancer
2
Durvalumab Shows Similar Outcomes Across NSCLC PD-L1 Expression Groups
3
GLP-1 Receptor Agonists Show Modest Reduction in HR+ Breast Cancer Incidence
4
What Is the Utility of Tumor Growth Rate in Glioma Treatment?
5